Imjudo 300mg Injection 15ml

Imjudo 300mg Injection 15ml is FDA-approved for the treatment of:

• Unresectable hepatocellular carcinoma (a type of liver cancer), in combination with durvalumab.
• Malignant pleural mesothelioma (a rare cancer affecting the lining of the lungs), in combination therapies.

This medicine works by helping the body’s immune system recognise and attack cancer cells more effectively. It does this by blocking a protein called CTLA-4 found on certain immune cells. Normally, this protein acts like a brake to prevent the immune system from overreacting. By blocking CTLA-4, Imjudo 300mg Injection 15ml removes this brake, allowing immune cells to stay active longer and fight off cancer cells more powerfully.

The result is a more persistent and stronger immune attack on tumours. This approach doesn’t target cancer directly but enhances the body’s natural defences. However, since it amplifies immune activity, it can also cause the immune system to mistakenly attack healthy tissues, which is why medical supervision is essential.

Imjudo 300mg Injection 15ml may interact seriously with other medicines, especially those that affect the immune system or cause inflammation in the body. It is important to inform your healthcare provider of all the medications you are taking, including over-the-counter drugs and herbal supplements.

Serious drug interactions include:

• Corticosteroids (like prednisone): These can reduce the effectiveness of the immune response triggered by this treatment.
• Immunosuppressants (such as cyclosporine, tacrolimus): May counteract the mechanism of Imjudo 300mg Injection 15ml.
• Live vaccines: Should be avoided during treatment, as the immune system may not respond as expected.
• Anti-TNF agents (like infliximab): May increase the risk of immune-related side effects such as colitis or pneumonitis.
• Other immune checkpoint inhibitors (such as nivolumab or pembrolizumab): When used without proper scheduling or monitoring, they may increase the chances of severe immune system reactions.

Always discuss your full medical history with your doctor before starting therapy. Avoid combining this medication with others unless advised and closely monitored.

• Store in a refrigerator between 2°C to 8°C. Do not freeze.
• Do not shake the vial. Protect from light.
• If a dose is missed, inform your doctor immediately. Do not self-administer extra doses.
• In case of overdose, seek emergency medical help. Symptoms may include severe fatigue, fever, or organ-related issues.

Imjudo 300mg Injection 15ml is given as an intravenous infusion (IV) by a healthcare professional in a clinical setting. The dosage and schedule are decided based on the patient's weight, type of cancer, and overall health. It is not taken with food or at home. It is often given in combination with other medications like durvalumab, usually once every few weeks. Do not attempt to self-administer or alter the treatment schedule without medical guidance.

Common Side Effects:

• Tiredness or fatigue
• Diarrhoea or abdominal pain
• Skin rash or itching
• Loss of appetite
• Joint or muscle pain

Serious Side Effects:

• Severe diarrhoea or colitis
• Breathing difficulty or chest tightness (signs of pneumonitis)
• Yellowing of the skin or eyes (possible liver issues)
• Hormonal problems like thyroid imbalance
• Eye inflammation or vision problems

Report any unusual or persistent symptoms to your healthcare provider immediately.

Imjudo 300mg Injection 15ml is a powerful cancer treatment and should only be used under specialist supervision. Patients should attend all scheduled appointments for lab monitoring and report any side effects early. Do not start new medications or supplements without informing your oncologist, as they may interfere with your immune response. Always carry a medical information card that mentions you are receiving immunotherapy. Stay hydrated, eat well, and follow your doctor’s lifestyle advice to support your recovery and treatment outcomes.